Risk of severe allergic reaction higher with two IV intravenous iron-boosting products
Study shows safety of vaccinating children against COVID-19 after previous MIS-C diagnosis
28 March 2022Equal is better? How people think COVID-19 vaccines should be shared worldwide
28 March 2022Risk of severe allergic reaction higher with two IV intravenous iron-boosting products
Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a study analyzing the medical records in a large database of older Medicare patients.
